Treatment of Hoarseness from GERD

Diagnostic Approach

The American Academy of Otolaryngology-Head and Neck Surgery recommends against empiric PPI therapy for hoarseness without documented laryngeal inflammation, and instead suggests performing laryngoscopy to look for specific findings such as erythema, edema, and surface irregularities of the laryngeal mucosa 1, 2
If laryngoscopy is normal or shows no inflammation, anti-reflux medications should not be prescribed, as randomized trials show no benefit and significant potential harms 1, 2
If chronic laryngitis is documented on laryngoscopy, then PPI therapy becomes an option, with the American Academy of Otolaryngology-Head and Neck Surgery explicitly recommending against empiric PPI therapy for hoarseness without documented laryngeal inflammation 1, 2, 3

The American Academy of Otolaryngology-Head and Neck Surgery suggests PPI therapy for 3-4 months, with standard dosing of omeprazole 20-40 mg daily or equivalent PPI, if laryngitis is documented on laryngoscopy 3, 4, 5
Lifestyle modifications, including dietary changes, weight management, and avoiding late meals, are also recommended 6

Long-term PPI therapy carries significant risks, including increased risk of hip fractures in older adults, vitamin B12 deficiency, iron deficiency anemia, increased risk of pancreatitis, and risk of Clostridium difficile infection 1, 3, 4, 9

A Cochrane systematic review of 302 studies found no high-quality trials supporting PPI use for hoarseness without documented GERD symptoms, with the American Gastroenterological Association recommending upfront objective reflux testing rather than empiric PPI trial in patients with isolated extra-esophageal symptoms like hoarseness 1, 2, 6, 7, 8

If hoarseness persists despite appropriate evaluation and treatment, consider other causes such as vocal cord lesions, neurologic disorders, neoplasms, and voice overuse, and refer to otolaryngology for comprehensive voice evaluation 1, 4, 5